Identifying Novel Enhancers of the Antitumour Immune Response for Cancer Immunotherapy
Immunotherapy is a promising tool in the fight against cancer and aims to recruit patients own immune systems to seek out and destroy malignant cells. Options such as oncolytic viruses (OVs), autologous tumour vaccines and chimeric antigen receptors have shown clinical success to date, yet there rem...
Main Author: | Varette, Oliver |
---|---|
Other Authors: | Diallo, Jean-Simon |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/42423 http://dx.doi.org/10.20381/ruor-26643 |
Similar Items
-
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
by: Tao Shi, et al.
Published: (2020-04-01) -
High-throughput screening to enhance oncolytic virus immunotherapy
by: Allan KJ, et al.
Published: (2016-04-01) -
Combination strategies to maximize the benefits of cancer immunotherapy
by: Shaoming Zhu, et al.
Published: (2021-09-01) -
The Intriguing History of Cancer Immunotherapy
by: Paula Dobosz, et al.
Published: (2019-12-01) -
Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy
by: Stephanie L. Swift, et al.
Published: (2016-02-01)